Our gene differential expression analysis showed that compared with the healthy group, both sepsis and COVID-19 patient groups exhibited the significantly upregulated expression levels of TLR4, suggesting that synergistic treatment of these two diseases could be implemented by regulating TLR4 target gene. This evidence concerns the gene TLR4 and COVID-19.